An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis
Clinical trial NCT06645197 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06645197
- Sponsor
- Peking University Third Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2025-04-15
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.